UnitedHealth Group reported strong Q1 results with a 13% increase in revenues to $55.2 billion and a 28% rise in adjusted net earnings per share to $3.04. The company raised its full-year earnings guidance, indicating confidence in continued growth, and highlighted positive developments across its business segments, including Optum and Medicare Advantage. The upbeat management tone and strategic investments suggest a positive short-term impact on the stock price.

[1]